Alliancebernstein L.P. Repligen Corp Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Repligen Corp stock. As of the latest transaction made, Alliancebernstein L.P. holds 819,457 shares of RGEN stock, worth $118 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

819,457

Previous 823,744 0.52%

Holding current value

$118 Million

Previous $104 Million 17.44%

% of portfolio

0.04%

Previous 0.04%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$119.79 - $167.35 $513,539 - $717,429	-4,287 Reduced 0.52%	819,457 $122 Million
Q2 2024 Aug 14, 2024	SELL	$120.0 - $182.95 $2.4 Million - $3.66 Million	-20,002 Reduced 2.37%	823,744 $104 Million
Q1 2024 May 14, 2024	BUY	$170.78 - $208.42 $11.4 Million - $13.9 Million	66,721 Added 8.59%	843,746 $155 Million
Q4 2023 Feb 14, 2024	SELL	$114.17 - $185.35 $922,721 - $1.5 Million	-8,082 Reduced 1.03%	777,025 $140 Million
Q3 2023 Nov 14, 2023	BUY	$138.78 - $176.51 $2.43 Million - $3.1 Million	17,540 Added 2.29%	785,107 $125 Million
Q2 2023 Aug 15, 2023	SELL	$138.42 - $180.31 $14.5 Million - $18.9 Million	-104,967 Reduced 12.03%	767,567 $109 Million
Q1 2023 May 15, 2023	SELL	$154.26 - $198.1 $31.9 Million - $40.9 Million	-206,571 Reduced 19.14%	872,534 $147 Million
Q4 2022 Feb 14, 2023	BUY	$162.42 - $220.56 $43.4 Million - $59 Million	267,436 Added 32.95%	1,079,105 $183 Million
Q3 2022 Nov 15, 2022	SELL	$160.42 - $256.21 $56 Million - $89.4 Million	-348,815 Reduced 30.06%	811,669 $152 Million
Q2 2022 Aug 15, 2022	SELL	$140.68 - $188.02 $17.3 Million - $23.1 Million	-123,101 Reduced 9.59%	1,160,484 $188 Million
Q1 2022 May 13, 2022	BUY	$161.19 - $257.96 $38.9 Million - $62.3 Million	241,386 Added 23.16%	1,283,585 $241 Million
Q4 2021 Feb 14, 2022	SELL	$247.59 - $304.47 $24.1 Million - $29.6 Million	-97,319 Reduced 8.54%	1,042,199 $276 Million
Q3 2021 Nov 10, 2021	SELL	$194.77 - $324.21 $24.8 Million - $41.2 Million	-127,112 Reduced 10.04%	1,139,518 $329 Million
Q2 2021 Jul 30, 2021	BUY	$165.87 - $220.95 $24 Million - $32 Million	144,624 Added 12.89%	1,266,630 $253 Million
Q1 2021 May 06, 2021	BUY	$180.37 - $226.26 $6.58 Million - $8.25 Million	36,479 Added 3.36%	1,122,006 $218 Million
Q4 2020 Feb 08, 2021	SELL	$148.08 - $206.57 $6.71 Million - $9.37 Million	-45,346 Reduced 4.01%	1,085,527 $208 Million
Q3 2020 Nov 12, 2020	SELL	$122.51 - $158.27 $28.6 Million - $36.9 Million	-233,168 Reduced 17.09%	1,130,873 $167 Million
Q2 2020 Aug 13, 2020	BUY	$94.33 - $140.48 $36.1 Million - $53.8 Million	382,998 Added 39.04%	1,364,041 $169 Million
Q1 2020 May 14, 2020	BUY	$84.96 - $109.14 $69.4 Million - $89.1 Million	816,822 Added 497.39%	981,043 $94.7 Million
Q4 2019 Feb 18, 2020	BUY	$73.84 - $93.08 $675,636 - $851,682	9,150 Added 5.9%	164,221 $15.2 Million
Q3 2019 Nov 14, 2019	BUY	$76.65 - $95.51 $2.92 Million - $3.64 Million	38,140 Added 32.62%	155,071 $11.9 Million
Q2 2019 Aug 14, 2019	BUY	$54.2 - $85.95 $1.28 Million - $2.04 Million	23,690 Added 25.41%	116,931 $10.1 Million
Q1 2019 May 14, 2019	SELL	$49.45 - $62.8 $262,085 - $332,840	-5,300 Reduced 5.38%	93,241 $5.51 Million
Q4 2018 Feb 13, 2019	BUY	$48.26 - $68.88 $1.75 Million - $2.49 Million	36,211 Added 58.1%	98,541 $5.2 Million
Q2 2018 Aug 13, 2018	BUY	$35.26 - $47.04 $292,658 - $390,432	8,300 Added 15.36%	62,330 $2.93 Million
Q1 2018 May 14, 2018	BUY	$30.92 - $37.27 $58,748 - $70,813	1,900 Added 3.64%	54,030 $1.96 Million
Q3 2017 Nov 13, 2017	BUY	$36.98 - $46.06 $1.93 Million - $2.4 Million	52,130	52,130 $2 Million

Others Institutions Holding RGEN

# of Institutions

488

Shares Held

54.2M

Call Options Held

341K

Put Options Held

235K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.98B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Repligen Corp Transaction History